Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Ulrich Santo who wrote (11173)	7/10/1998 6:38:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

US, For some reason short interest has always been high in Vivus at about 9 to 10 million. I assume there are a lot of hedged positions along with some short only positions. Vivus should not see any short squeeze soon. If the domestic prescription numbers rise then we should see a steady increase in share price. An announcement of a domestic partner can help give another quick run to 10. A buyout announcement would result in a gap up to whatever the buyout price is.